Suppr超能文献

ADAMTS13 基因和 SUPT3H 基因中的遗传变异与 ADAMTS13 活性相关。

Genetic variants in the ADAMTS13 and SUPT3H genes are associated with ADAMTS13 activity.

机构信息

Department of Epidemiology.

Department of Hematology.

出版信息

Blood. 2015 Jun 18;125(25):3949-55. doi: 10.1182/blood-2015-02-629865. Epub 2015 May 1.

Abstract

A disintegrin and metalloproteinase with thrombospondin motifs 13 (ADAMTS13) cleaves von Willebrand factor, reducing its prothrombotic activity. The genetic determinants of ADAMTS13 activity remain unclear. We performed a genome-wide association study of ADAMTS13 activity in the Rotterdam Study, a population-based cohort study. We used imputed genotypes of common variants in a discovery sample of 3443 individuals and replication sample of 2025 individuals. We examined rare exonic variant associations in ADAMTS13 in 1609 individuals using an exome array. rs41314453 in ADAMTS13 was associated with ADAMTS13 activity in both our discovery (β, -20.2%; P = 1.3 × 10(-33)) and replication sample (P = 3.3 × 10(-34)), and explained 3.6% to 6.5% of the variance. In the combined analysis of our discovery and replication samples, there were 2 further independent associations at the ADAMTS13 locus: rs3118667 (β, 3.0; P = 9.6 × 10(-21)) and rs139911703 (β, -11.6; P = 3.6 × 10(-8)). In addition, rs10456544 in SUPT3H was associated with a 4.2 increase in ADAMTS13 activity (P = 1.13.6 × 10(-8)). Finally, we found 3 independent associations with rare coding variants in ADAMTS13: rs148312697 (β, -32.2%; P = 3.7 × 10(-6)), rs142572218 (β, -46.0%; P = 3.9 × 10(-5)), and rs36222275 (β, -13.9%; P = 2.9 × 10(-3)). In conclusion, we identified rs41314453 as the main genetic determinant of ADAMTS13 activity, and we present preliminary findings for further associations at the ADAMTS13 and SUPT3H loci.

摘要

一种含有血栓反应蛋白基序的解整合素金属蛋白酶 13(ADAMTS13)可切割血管性血友病因子,从而降低其促血栓形成活性。ADAMTS13 活性的遗传决定因素尚不清楚。我们在基于人群的鹿特丹研究中进行了 ADAMTS13 活性的全基因组关联研究。我们在 3443 名个体的发现样本和 2025 名个体的复制样本中使用常见变体的导入基因型。我们使用外显子组芯片在 1609 名个体中检查了 ADAMTS13 中罕见的外显子变异关联。rs41314453 在 ADAMTS13 中与我们的发现(β,-20.2%;P=1.3×10(-33))和复制样本(P=3.3×10(-34))中的 ADAMTS13 活性相关,解释了 3.6%至 6.5%的方差。在我们的发现和复制样本的合并分析中,ADAMTS13 基因座上还有另外两个独立的关联:rs3118667(β,3.0;P=9.6×10(-21))和 rs139911703(β,-11.6;P=3.6×10(-8))。此外,SUPT3H 中的 rs10456544 与 ADAMTS13 活性增加 4.2 有关(P=1.13.6×10(-8))。最后,我们发现 ADAMTS13 中存在 3 个与罕见编码变异相关的独立关联:rs148312697(β,-32.2%;P=3.7×10(-6))、rs142572218(β,-46.0%;P=3.9×10(-5))和 rs36222275(β,-13.9%;P=2.9×10(-3))。总之,我们确定 rs41314453 为 ADAMTS13 活性的主要遗传决定因素,并提出了 ADAMTS13 和 SUPT3H 基因座进一步关联的初步发现。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验